{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE344nnn/GSE344886/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Homo sapiens"],"gds_type":["Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE344886"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"RNA-seq analysis of bevacizumab-treated human glioblastoma cell line samples","description":"This study characterizes transcriptomic changes associated with bevacizumab treatment in a human glioblastoma cell-line model. RNA sequencing was performed on bevacizumab-treated and untreated control cell samples cultured on a chip. Because the original FASTQ files are corrupted/currently unavailable, this GEO submission includes metadata and processed RNA-seq data files only, as advised by the GEO team under NCBI tracking system #25983490.","dates":{"publication":"2026/08/29"},"accession":"GSE344886","cross_references":{"GSM":["GSM9986995","GSM9986996","GSM9986993","GSM9986994","GSM9986991","GSM9986992"],"GPL":["24676"],"GSE":["344886"],"taxon":["Homo sapiens"]}}